tirzepatide consent form for weight loss free | Mounjaro & Zepbound Injection Agreement | GLP-1 and Diabetes Informed Consent | Editable Word PDF Compounded Tirzepatide (GLP-1/GIP) - 4th

For most people, an FDA-approved brand or oral option is now the safer path

While generally consistent with the known class effects of GLP-1 receptor agonists, these side effects may impact long-term adherence and should be carefully considered in clinical decision-making

The pharmacokinetic concern is more relevant to other medications a patient may take concurrently

Wegovy is a prescription weight loss injection containing semaglutide, part of a group of medications called a GLP-1 (glucagon-like peptide-1)

Combining them may increase the likelihood of gastrointestinal discomfort, especially during the first few weeks of treatment

GLP-1 medications are not quick fixes and should be used as part of a long-term approach involving lifestyle changes